[6-(6-bromoindazol-1-yl)pyrazin-2-yl]methoxy-tert-butyl-dimethylsilane;tert-butyl-dimethyl-[[6-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]pyrazin-2-yl]methoxy]silane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane

C54H82B3BrN8O8Si2 — CID 160838511

IUPAC[6-(6-bromoindazol-1-yl)pyrazin-2-yl]methoxy-tert-butyl-dimethylsilane;tert-butyl-dimethyl-[[6-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]pyrazin-2-yl]methoxy]silane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane
SMILESCC(C)(C)[Si](C)(C)OCc1cncc(-n2ncc3ccc(Br)cc32)n1.CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CC1(C)OB(c2ccc3cnn(-c4cncc(CO[Si](C)(C)C(C)(C)C)n4)c3c2)OC1(C)C
InChIInChI=1S/C24H35BN4O3Si.C18H23BrN4OSi.C12H24B2O4/c1-22(2,3)33(8,9)30-16-19-14-26-15-21(28-19)29-20-12-18(11-10-17(20)13-27-29)25-31-23(4,5)24(6,7)32-25;1-18(2,3)25(4,5)24-12-15-10-20-11-17(22-15)23-16-8-14(19)7-6-13(16)9-21-23;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14/h10-15H,16H2,1-9H3;6-11H,12H2,1-5H3;1-8H3
InChIKeySHSFPDCKJXKDPD-UHFFFAOYSA-N
MW1139.81 g/mol
LogP11.99
Rot. Bonds10

About [6-(6-bromoindazol-1-yl)pyrazin-2-yl]methoxy-tert-butyl-dimethylsilane;tert-butyl-dimethyl-[[6-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]pyrazin-2-yl]methoxy]silane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane

[6-(6-bromoindazol-1-yl)pyrazin-2-yl]methoxy-tert-butyl-dimethylsilane;tert-butyl-dimethyl-[[6-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]pyrazin-2-yl]methoxy]silane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane (PubChem CID 160838511) has the molecular formula C54H82B3BrN8O8Si2 and a molecular weight of 1139.81 g/mol. Its IUPAC name is [6-(6-bromoindazol-1-yl)pyrazin-2-yl]methoxy-tert-butyl-dimethylsilane;tert-butyl-dimethyl-[[6-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]pyrazin-2-yl]methoxy]silane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane.

Molecular Properties

Compound Name[6-(6-bromoindazol-1-yl)pyrazin-2-yl]methoxy-tert-butyl-dimethylsilane;tert-butyl-dimethyl-[[6-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]pyrazin-2-yl]methoxy]silane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane
PubChem CID160838511
Molecular FormulaC54H82B3BrN8O8Si2
Molecular Weight1139.81 g/mol
Exact Mass1138.53
IUPAC Name[6-(6-bromoindazol-1-yl)pyrazin-2-yl]methoxy-tert-butyl-dimethylsilane;tert-butyl-dimethyl-[[6-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]pyrazin-2-yl]methoxy]silane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane
SMILESCC(C)(C)[Si](C)(C)OCc1cncc(-n2ncc3ccc(Br)cc32)n1.CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CC1(C)OB(c2ccc3cnn(-c4cncc(CO[Si](C)(C)C(C)(C)C)n4)c3c2)OC1(C)C
InChIInChI=1S/C24H35BN4O3Si.C18H23BrN4OSi.C12H24B2O4/c1-22(2,3)33(8,9)30-16-19-14-26-15-21(28-19)29-20-12-18(11-10-17(20)13-27-29)25-31-23(4,5)24(6,7)32-25;1-18(2,3)25(4,5)24-12-15-10-20-11-17(22-15)23-16-8-14(19)7-6-13(16)9-21-23;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14/h10-15H,16H2,1-9H3;6-11H,12H2,1-5H3;1-8H3
InChIKeySHSFPDCKJXKDPD-UHFFFAOYSA-N
XLogP11.99
TPSA161.04 Ų
H-Bond Donors
H-Bond Acceptors16
Rotatable Bonds10
Heavy Atoms76
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001139.81
LogP ≤ 511.99
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze [6-(6-bromoindazol-1-yl)pyrazin-2-yl]methoxy-tert-butyl-dimethylsilane;tert-butyl-dimethyl-[[6-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]pyrazin-2-yl]methoxy]silane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [6-(6-bromoindazol-1-yl)pyrazin-2-yl]methoxy-tert-butyl-dimethylsilane;tert-butyl-dimethyl-[[6-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]pyrazin-2-yl]methoxy]silane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?
The IUPAC name of [6-(6-bromoindazol-1-yl)pyrazin-2-yl]methoxy-tert-butyl-dimethylsilane;tert-butyl-dimethyl-[[6-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]pyrazin-2-yl]methoxy]silane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane (CID 160838511) is [6-(6-bromoindazol-1-yl)pyrazin-2-yl]methoxy-tert-butyl-dimethylsilane;tert-butyl-dimethyl-[[6-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]pyrazin-2-yl]methoxy]silane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane.
What is the SMILES notation for [6-(6-bromoindazol-1-yl)pyrazin-2-yl]methoxy-tert-butyl-dimethylsilane;tert-butyl-dimethyl-[[6-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]pyrazin-2-yl]methoxy]silane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?
The canonical SMILES for [6-(6-bromoindazol-1-yl)pyrazin-2-yl]methoxy-tert-butyl-dimethylsilane;tert-butyl-dimethyl-[[6-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]pyrazin-2-yl]methoxy]silane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane is CC(C)(C)[Si](C)(C)OCc1cncc(-n2ncc3ccc(Br)cc32)n1.CC1(C)OB(B2OC(C)(C)C(C)(C)O2)OC1(C)C.CC1(C)OB(c2ccc3cnn(-c4cncc(CO[Si](C)(C)C(C)(C)C)n4)c3c2)OC1(C)C.
What is the InChIKey of [6-(6-bromoindazol-1-yl)pyrazin-2-yl]methoxy-tert-butyl-dimethylsilane;tert-butyl-dimethyl-[[6-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]pyrazin-2-yl]methoxy]silane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?
The InChIKey is SHSFPDCKJXKDPD-UHFFFAOYSA-N. The full InChI is InChI=1S/C24H35BN4O3Si.C18H23BrN4OSi.C12H24B2O4/c1-22(2,3)33(8,9)30-16-19-14-26-15-21(28-19)29-20-12-18(11-10-17(20)13-27-29)25-31-23(4,5)24(6,7)32-25;1-18(2,3)25(4,5)24-12-15-10-20-11-17(22-15)23-16-8-14(19)7-6-13(16)9-21-23;1-9(2)10(3,4)16-13(15-9)14-17-11(5,6)12(7,8)18-14/h10-15H,16H2,1-9H3;6-11H,12H2,1-5H3;1-8H3.
What are the key properties of [6-(6-bromoindazol-1-yl)pyrazin-2-yl]methoxy-tert-butyl-dimethylsilane;tert-butyl-dimethyl-[[6-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]pyrazin-2-yl]methoxy]silane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane?
[6-(6-bromoindazol-1-yl)pyrazin-2-yl]methoxy-tert-butyl-dimethylsilane;tert-butyl-dimethyl-[[6-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]pyrazin-2-yl]methoxy]silane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane has a molecular weight of 1139.81 g/mol, XLogP of 11.99, 10 rotatable bonds, 0 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for [6-(6-bromoindazol-1-yl)pyrazin-2-yl]methoxy-tert-butyl-dimethylsilane;tert-butyl-dimethyl-[[6-[6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]pyrazin-2-yl]methoxy]silane;4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane is sourced from PubChem (CID 160838511), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).